MAGE-A4-derived HLA-A*02:01-restricted candidate epitopes | Download Scientific Diagram
Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4 | Journal of Medicinal Chemistry
Dieter 'Hovekamp)))🇺🇦👥🤝👥🇷🇺 ☮️🕊️ on Twitter: "$BLUE talking about $MDGEF #TCR MAGE-A4 refering to $ADAP recent success for solid cancers ! https://t.co/X5hKVzNqH9" / Twitter
Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with advanced solid tumors | MD Anderson Cancer Center
T-cell receptor-like antibodies directed against intracellular tumor targets for immunotherapy of solid tumors
siTCR™ | Gene Therapy | TAKARA BIO INC.
PRAME of reference clarifies (MAGE-A4, too) as research rolls on | BioWorld
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy | Journal for ImmunoTherapy of Cancer
T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human | Cell Death & Disease
Technology :: Adaptimmune Therapeutics plc (ADAP)
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy | Journal for ImmunoTherapy of Cancer
Medigene — TCR enters the clinic - Edison Group
Adaptimmune and TCR2 Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors
siTCR™ | Gene Therapy | TAKARA BIO INC.
Dieter 'Hovekamp)))🇺🇦👥🤝👥🇷🇺 ☮️🕊️ on Twitter: "$ADAP $BLUE $MDGEF with continued promising data from Adaptimmune it will be interesting to see if a competition in solid tumours by bluebird Bio finally starts in
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy | Journal for ImmunoTherapy of Cancer
Asco 2021 – Adaptimmune's T-cell receptors see a route to market | Evaluate
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression: Molecular Therapy - Nucleic Acids
T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human | Cell Death & Disease
Frontiers | Empirical and Rational Design of T Cell Receptor-Based Immunotherapies
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy | Journal for ImmunoTherapy of Cancer
Exclusive License Agreements to Develop... - Zelluna Immunotherapy AS
T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4 - ScienceDirect
T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4 - ScienceDirect
